0 Évaluations

ID

11850

Description

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology; ODM derived from: https://clinicaltrials.gov/show/NCT02140736

Lien

https://clinicaltrials.gov/show/NCT02140736

Mots-clés

  1. 10/08/2015 10/08/2015 - Julian Varghese
Téléchargé le

10 août 2015

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Chemotherapy-induced Symptomatic Anemia NCT02140736

    Eligibility Chemotherapy-induced Symptomatic Anemia NCT02140736

    Inclusion Criteria
    Description

    Inclusion Criteria

    patients of more than 18 years of age
    Description

    patients of more than 18 years of age

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    patients presenting with anemia following chemotherapy
    Description

    patients presenting with anemia following chemotherapy

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C3665472
    UMLS CUI [2]
    C0002871
    patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy
    Description

    patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0280100
    UMLS CUI [2]
    C3665472
    UMLS CUI [3]
    C0376545
    - the patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)
    Description

    - the patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)

    Type de données

    boolean

    patients eligible for epoetin alfa biosimilar treatment
    Description

    patients eligible for epoetin alfa biosimilar treatment

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0013893
    UMLS CUI [1,2]
    C0357126
    Exclusion Criteria
    Description

    Exclusion Criteria

    patients are not receiving chemotherapy
    Description

    patients are not receiving chemotherapy

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C3665472
    patients already included in an epoetin zeta trial
    Description

    patients already included in an epoetin zeta trial

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C2242969
    UMLS CUI [1,2]
    C1997870
    patients presenting with a contraindication to epoetin zeta
    Description

    patients presenting with a contraindication to epoetin zeta

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0522473
    UMLS CUI [1,2]
    C1997870
    patients presenting with hypersensitivity to the active principle or any of the excipients
    Description

    patients presenting with hypersensitivity to the active principle or any of the excipients

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C0014822
    patient with erythroblastopenia or acquired pure red cell aplasia (aprca)
    Description

    patient with erythroblastopenia or acquired pure red cell aplasia (aprca)

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0877221
    UMLS CUI [2]
    C0340961
    patient with uncontrollable arterial hypertension
    Description

    patient with uncontrollable arterial hypertension

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1868885
    patients who cannot receive adequate prophylaxis by antithrombotic agents
    Description

    patients who cannot receive adequate prophylaxis by antithrombotic agents

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0522473
    UMLS CUI [1,2]
    C1704311

    Similar models

    Eligibility Chemotherapy-induced Symptomatic Anemia NCT02140736

    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    age
    Item
    patients of more than 18 years of age
    boolean
    C0001779 (UMLS CUI [1])
    Chemotherapy | Anemia | Hematologic Neoplasms
    Item
    patients presenting with anemia following chemotherapy
    boolean
    C3665472 (UMLS CUI [1])
    C0002871 (UMLS CUI [2])
    Solid tumour | Chemotherapy | Hematologic Neoplasms
    Item
    patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy
    boolean
    C0280100 (UMLS CUI [1])
    C3665472 (UMLS CUI [2])
    C0376545 (UMLS CUI [3])
    patient inclusion regardless of chemotherapy
    Item
    - the patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)
    boolean
    Eligibility Determination; Epoetin Alfa
    Item
    patients eligible for epoetin alfa biosimilar treatment
    boolean
    C0013893 (UMLS CUI [1,1])
    C0357126 (UMLS CUI [1,2])
    Chemotherapy
    Item
    patients are not receiving chemotherapy
    boolean
    C3665472 (UMLS CUI [1])
    clinical trial participant (history); epoetin zeta
    Item
    patients already included in an epoetin zeta trial
    boolean
    C2242969 (UMLS CUI [1,1])
    C1997870 (UMLS CUI [1,2])
    Contraindication; epoetin zeta
    Item
    patients presenting with a contraindication to epoetin zeta
    boolean
    C0522473 (UMLS CUI [1,1])
    C1997870 (UMLS CUI [1,2])
    Hypersensitivity; Erythropoietin
    Item
    patients presenting with hypersensitivity to the active principle or any of the excipients
    boolean
    C0020517 (UMLS CUI [1,1])
    C0014822 (UMLS CUI [1,2])
    Decreased erythroid precursor production | Acquired red cell aplasia
    Item
    patient with erythroblastopenia or acquired pure red cell aplasia (aprca)
    boolean
    C0877221 (UMLS CUI [1])
    C0340961 (UMLS CUI [2])
    Uncontrolled hypertension
    Item
    patient with uncontrollable arterial hypertension
    boolean
    C1868885 (UMLS CUI [1])
    Contraindication; Antithrombotic Agents
    Item
    patients who cannot receive adequate prophylaxis by antithrombotic agents
    boolean
    C0522473 (UMLS CUI [1,1])
    C1704311 (UMLS CUI [1,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial